APOE and hyperlipidemia: Interestingly, these serum lipid parameters were unaffected by luseogliflozin administration to NA/STZ-treated ApoE KO mice (Figure 4D), although the NA/STZ-induced diabetic state was associated with more severe hyperlipidemia.